Imaging flow cytometry for automated detection of hypoxia-induced erythrocyte shape change in sickle cell disease

American Journal of Hematology

Volumn 89, Issue 6, 2014, Pages 598-603

  Van Beers, Eduard J ^a   Samsel, Leigh ^a   Mendelsohn, Laurel ^a   Saiyed, Rehan ^a   Fertrin, Kleber Y ^a   Brantner, Christine A ^a   Daniels, Mathew P ^a   Nichols, James ^a   McCoy, J Philip ^a   Kato, Gregory J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYMETHYLFURFURAL; AES 103; ANTISICKLING AGENT; HEMOGLOBIN F; UNCLASSIFIED DRUG;

ALGORITHM; ARTICLE; AUTOMATION; BLOOD PH; CONTROLLED STUDY; DEOXYGENATION; ERYTHROCYTE SHAPE; ERYTHROCYTE STRUCTURE; FLOW CYTOMETER; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; INTRACELLULAR SPACE; OXYGEN TENSION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SICKLE CELL ANEMIA; SICKLE IMAGING FLOW CYTOMETRY ASSAY; TRANSMISSION ELECTRON MICROSCOPY;

ANEMIA, SICKLE CELL; AUTOMATION; CELL HYPOXIA; ERYTHROCYTES; ERYTHROCYTES, ABNORMAL; FLOW CYTOMETRY; HUMANS; OXYGEN;

EID: 84900864121     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23699     Document Type: Article

References (31)

1. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2163-2196.
2. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 2010; 376:2018-2031.
3. Lin T, Kwak YH, Sammy F, et al. Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. J Infect Dis 2010;202:624-32.
4. Christoph GW, Hofrichter J, Eaton WA. Understanding the shape of sickled red cells. Biophys J 2005;88:1371-1376.
5. Noguchi CT, Schechter AN. The intracellular polymerization of sickle hemoglobin and its relevance to sickle cell disease. Blood 1981;58:1057-1068.
6. Afolabi IS, Osikoya IO, Fajimi OD, et al. Solenostemon monostachyus, Ipomoea involucrata and Carica papaya seed oil versus Glutathione, or Vernonia amygdalina: Methanolic extracts of novel plants for the management of sickle cell anemia disease. BMC Complement Altern Med 2012;12:262.
7. Noguchi CT, Rodgers GP, Serjeant G, Schechter AN. Levels of fetal hemoglobin necessary for treatment of sickle cell disease. N Engl J Med 1988;318:96-99.
8. Akinsheye I, Alsultan A, Solovieff N, et al. Fetal hemoglobin in sickle cell anemia. Blood 2011;118:19-27.
9. Charache S, Barton FB, Moore RD, et al. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The multicenter study of hydroxyurea in sickle cell anemia. Medicine (Baltimore) 1996;75:300-326.
10. Presley TD, Perlegas AS, Bain LE, et al. Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes. Hemoglobin 2010;34:24-36.
11. Abdulmalik O, Safo MK, Chen Q, et al. 5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells. Br J Haematol 2005;128:552-561.
12. Chang H, Ewert SM, Bookchin RM, Nagel RL. Comparative evaluation of fifteen anti-sickling agents. Blood 1983;61:693-704.
13. Charache S, Conley CL. Rate of sickling of red cells during deoxygenation of blood from persons with various sickling disorders. Blood 1964;24:25-48.
14. Chang H, Ewert SM, Nagel RL. Identification of 2-imidazolines as anti-sickling agents. Mol Pharmacol 1983;23:731-734.
15. Ikuta T, Thatte HS, Tang JX, et al. Nitric oxide reduces sickle hemoglobin polymerization: Potential role of nitric oxide-induced charge alteration in depolymerization. Arch Biochem Biophys 2011;510:53-61.
16. Amnis Corporation. Image Data Exploration and Analysis Software User's Manual. Amnis Corporation, Seattle, WA, 2009.
17. Acquaye C, Blanchette-Mackie EJ, Reindorf C, et al. Electron microscopic studies of the intracellular polymerization of sickle hemoglobin. Blood Cells 1988;13:359-376.
18. Brittenham GM, Schechter AN, Noguchi CT. Hemoglobin S polymerization: Primary determinant of the hemolytic and clinical severity of the sickling syndromes. Blood 1985;65:183-189.
19. Sorette MP, Lavenant MG, Clark MR. Ektacytometric measurement of sickle cell deformability as a continuous function of oxygen tension. Blood 1987;69:316-323.
20. Frenette PS, Atweh GF. Sickle cell disease: Old discoveries, new concepts, and future promise. J Clin Invest 2007;117:850-858.
21. Wong P. A basis of the acanthocytosis in inherited and acquired disorders. Med Hypotheses 2004;62:966-969.
22. Altomare I, Desman G, Aledort LM. Echinocytosis-An unusual manifestation of hemangioma. Am J Hematol 2006;81:532-534.
23. Reinhart WH, Chien S. Echinocyte-stomatocyte transformation and shape control of human red blood cells: Morphological aspects. Am J Hematol 1987;24:1-14.
24. Shonat RD, Johnson PC. Oxygen tension gradients and heterogeneity in venous microcirculation: A phosphorescence quenching study. Am J Physiol Heart Circ Physiol 1997;272:H2233-H2240.
25. Kaul DK, Fabry ME, Nagel RL. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiological implications. Proc Natl Acad Sci USA 1989;86:3356-3360.
26. Pittman RN. Oxygen transport in the microcirculation and its regulation. Microcirculation 2013;20:117-137.
27. Tsai AG, Johnson PC, Intaglietta M. Oxygen gradients in the microcirculation. Physiol Rev 2003;83:933-963.
28. Asakura T, Asakura K, Obata K, et al. Blood samples collected under venous oxygen pressure from patients with sickle cell disease contain a significant number of a new type of reversibly sickled cells: Constancy of the percentage of sickled cells in individual patients during steady state. Am J Hematol 2005;80:249-256.
29. Sproule BJ, Halden ER, Miller WF. A study of cardiopulmonary alterations in patients with sickle cell disease and its variants. J Clin Invest 1958;37:486-495.
30. Barreras L, Diggs LW. Bicarbonates, PH and percentage of sickled cells in venous blood of patients in sickle cell crisis. Am J Med Sci 1964;247:710-718.
31. Kenny MW, Meakin M, Worthington DJ, Stuart J. Erythrocyte deformability in sickle-cell crisis. Br J Haematol 1981;49:103-109.